Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Castilla Cortázar, Inma ^a   García Fernández, María ^b   Delgado, Gloria ^b   Puche, Juan E ^a   Sierra, Inma ^a   Barhoum, Rima ^a   González Barón, Salvador ^b  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHOLESTEROL; FATTY ACID; INSULIN; SOMATOMEDIN B; SOMATOMEDIN C; TESTOSTERONE; TRIACYLGLYCEROL; ANTIOXIDANT; GLUCOSE; HORMONE; MALONALDEHYDE; PROTECTIVE AGENT;

AGE DISTRIBUTION; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DAMAGE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER INJURY; LIVER PROTECTION; LOW DRUG DOSE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEIC ACID SYNTHESIS; PROTEIN BLOOD LEVEL; RAT; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; BRAIN; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; HUMAN; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; LIVER MITOCHONDRION; MALE; METABOLISM; NERVOUS SYSTEM; OXIDATIVE STRESS; PROTEIN CARBONYLATION; WISTAR RAT;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HORMONES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LIPID METABOLISM; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA, LIVER; NERVOUS SYSTEM; OXIDATIVE STRESS; PROTECTIVE AGENTS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; TESTOSTERONE;

EID: 79959881826     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-103     Document Type: Article

References (40)

1. D'Ercole AJ, Ye P, O'Kusky JR. Mutant mouse models of insulin-like growth factor actions in the central nervous system. Neuropeptides 2002, 36:209-220. 10.1054/npep.2002.0893, 12359511.
2. Dupont J, Holzenberger M. Biology of insulin-like growth factors in development. Birth Defects Res Part C Embryo Today 2003, 69:257-271.
3. Fernandez S, Fernandez AM, Lopez-Lopez C, Torres-Aleman I. Emerging roles of insulin-like growth factor-I in the adult brain. Growth Horm IGF Res 2007, 17:89-95. 10.1016/j.ghir.2007.01.006, 17317256.
4. Garcia-Fernandez M, Delgado G, Puche JE, Salvador Gonzalez-Baron S, Castilla-Cortazar I. Low Doses of Insulin-Like Growth Factor I Improve Insulin Resistance, Lipid Metabolism, and Oxidative Damage in Aging Rats. Endocrinology 2008, 149(5):2433-2442. 10.1210/en.2007-1190, 18187555.
5. Puche JE, García-Fernández M, Muntané J, Rioja J, González-Barón S, Castilla Cortazar I. Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. Endocrinology 2008, 149:2620-7. 10.1210/en.2007-1563, 18276748.
6. Picardi A, de Oliveira AC, Muguerza B, Tosar A, Quiroga J, Castilla-Cortazar I, Santidrian S, Prieto J. Low doses of insulin-like growth factor-I improve nitrogen retention and food efficiency in rats with early cirrhosis. J Hepatol 1997, 26:191-202. 10.1016/S0168-8278(97)80026-8, 9148011.
7. Castilla-Cortazar I, Prieto J, Urdaneta E, Pascual M, Nuñez M, Zudaire E, Prieto J. Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology 1997, 113:1180-1187. 10.1053/gast.1997.v113.pm9322513, 9322513.
8. Castilla-Cortazar I, Picardi A, Ainzua J, Urdaneta E, Pascual M, Garci'a M, Pascual M, Quiroga J, Prieto J. Effect of insulin-like growth factor I on in vivo intestinal absorption of D-galactose in cirrhotic rats. Am J Physiol 1999, 276(1 Pt 1):37-42.
9. Castilla-Cortazar I, Pascual M, Urdaneta E, Pardo J, Puche JE, Vivas B, Diaz-Casares A, Garcia M, Diaz-Sanchez M, Varela-Nieto I, Castilla A, Gonzalez-Baron S. Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by insulin-like growth factor I. BMC Gastroenterol 2004, 4:12-20. 10.1186/1471-230X-4-12, 434503, 15196310.
10. Cemborain A, Castilla-Cortázar I, García M, Quiroga J, Muguerza B, Picardi A, Santidrian S, Prieto J. Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I-treatment. J Hepatol 1998, 28:122-131.
11. Castilla-Cortázar I, García M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, Diaz M, Prieto J. Insulin-like growth factor I reverts testicular atrophy in rats with advanced liver cirrhosis. Hepatology 2000, 31:592-600. 10.1002/hep.510310308, 10706548.
12. Castilla-Cortazar I, Diez N, Garcia-Fernandez M, Puche JE, Diez-Caballero F, Quiroga J, Diaz-Sanchez M, Castilla A, Casares AD, Varela-Nieto I, Prieto J, Gonzalez-Baron S. Hematotesticular barrier is altered from early stages of liver cirrhosis: effect of Insulin-like growth factor 1. World J Gastroenterol 2004, 10:2529-2534.
13. Castilla-Cortazar I, Garcia M, Muguerza B, Perez R, Quiroga J, Santidrian S, Prieto J. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 1997, 113:1682-1691. 10.1053/gast.1997.v113.pm9352873, 9352873.
14. Garcia-Fernandez M, Castilla-Cortazar I, Diaz-Sanchez M, Navarro I, Puche JE, Castilla A, Casares AD, Clavijo E, Gonzalez-Baron S. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol 2005, 5:7. 10.1186/1471-230X-5-7, 555751, 15745444.
15. García-Fernández M, Castilla-Cortázar I, Diaz-Sánchez M, Diez-Caballero F, Castilla A, Diaz Casares A, Varela-Nieto I, González-Barón S. Effect of IGF-I on total serum antioxidant status in cirrhotic rats. J Physiol Biochem 2003, 59:145-146. 10.1007/BF03179879, 14649879.
16. Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Avila M, Prieto J. Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 2002, 34:242-252. 10.1016/S1357-2725(01)00123-6, 11849991.
17. Gluckman PD, Ambler GR. What is the function of circulating insulin-like growth factor-2 in postnatal life?. Mol Cell Endocrinol 1993, 92(1):C1-C3. 10.1016/0303-7207(93)90067-T, 8472860.
18. Clemmons DR. Insulin-like Growth Factor Binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997, 8(1):45-62. 10.1016/S1359-6101(96)00053-6, 9174662.
19. Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, Galuppo P, Jakob M, Tsikas D, Anker SD, Poole-Wilson PA, Borlak J, Ertl G, Bauersachs J. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1. Circ Res 2007, 100:434-443. 10.1161/01.RES.0000257912.78915.af, 17234973.
20. Li Q, Wu S, Li SY, Lopez FL, Du M, Kajstura J, Anversa P, Ren J. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol Heart Circ Physiol 2007, 292:1398-403.
21. Trejo JL, Carro E, Lopez-Lopez C, Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res 2004, 14(Suppl A):S39-S43.
22. Miller NJ, Rice-Evans C, Davies MJ. A new method for measuring antioxidant activity. Biochem Soc Trans 1993, 21:95S.
23. National Academy of Sciences The guiding principles for research involving animals. 1991, Bethesda, MD: National Institutes of Health, National Academy of Sciences.
24. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004, 27:1487-1495. 10.2337/diacare.27.6.1487, 15161807.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
26. Voss P, Siems W. Clinical oxidation parameters of aging. Free Radic Res 2006, 40:1339-1349. 10.1080/10715760600953859, 17090423.
27. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad Biol Med 1991, 11:81-128. 10.1016/0891-5849(91)90192-6, 1937131.
28. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990, 186:464-478.
29. Harris ED. Regulation of antioxidant enzymes. FASEB J 1992, 6:2675-2683.
30. Aebi HE. Catalase. Methods of enzymatic analysis 1983, 273-286. Weimheim, Germany: Verlag Chemie, Bergmeyer HU, Bergmeyer J, Grassl M.
31. Hogeboom GH, Schneider WC. Sonic disintegration of isolated liver mitochondria. Nature 1950, 166:302-303. 10.1038/166302a0, 15439298.
32. O'Connor JE, Vargas JL, KimLer BF, Hernandez-Yago J, Grisolia S. Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 1988, 151:568-573. 10.1016/0006-291X(88)90632-8, 3348796.
33. Vega-Nunez E, Alvarez AM, Menendez-Hurtado A, Santos A, Perez-Castillo A. Neuronal mitochondrial morphology and transmembrane potential are severely altered by hypothyroidism during rat brain development. Endocrinology 1997, 138:3771-3778. 10.1210/en.138.9.3771, 9275064.
34. Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PD, Hintz RL, Hoffman AR. The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab 1998, 83:499-502. 10.1210/jc.83.2.499, 9467564.
35. Garcia-Segura LM, Sanz A, Mendez P. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection. Neuroendocrinology 2006, 84:275-279. 10.1159/000097485, 17124377.
36. Llorens-Martín M, Torres-Alemán I, Trejo JL. Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis. Neuroscientist 2009, 15:134-48. 10.1177/1073858408331371, 19307421.
37. Sullivan KA, Kim B, Feldman EL. Insulin-like growth factors in the peripheral nervous system. Endocrinology 2008, 149:5963-71. 10.1210/en.2008-1020, 2613061, 18719018.
38. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D, Blitzer RD, Alberini CM. A critical role for IGF-II in memory consolidation and enhancement. Nature 2011, 27;469(7331):491-7.
39. Cardoso SM, Pereira C, Oliveira CR. Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 1999, 26:3-13. 10.1016/S0891-5849(98)00205-6, 9890635.
40. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schwelver M, Suter M, Walter P, Yafffee M. Oxidant in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995, 1271:67-74.